Simpler Grants.gov #NOT-DE-26-006

NIH Presolicitation: Resource Centers for Tissue Engineering and Regenerative Medicine (APEx)

The National Institutes of Health (NIH), through the National Institute of Dental and Craniofacial Research (NIDCR), is preparing to release a Notice of Funding Opportunity (NOFO) for the Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) program. - NIH/NIDCR will fund extramural Resource Centers (RCs) to support tissue engineering and regenerative medicine (TE/RM) strategies and products - RCs will provide guidance to Interdisciplinary Translational Projects (ITPs) in areas such as therapeutics, sensors, and diagnostics - Support includes validation, manufacturing, and preclinical testing of TE/RM products - Focus on products for detecting or treating tissue damage from congenital defects, traumatic injury, or chronic disease - RCs will leverage expertise in clinical, scientific, industrial, regulatory, and commercialization domains - The goal is to develop TE/RM products with regulatory approvals and clinical trial protocols ready for first-in-human studies - No specific OEMs, vendors, products, or part numbers are identified in this presolicitation - This is an advance notice to allow potential applicants to prepare collaborations and projects

Description

The National Institute of Dental and Craniofacial Research (NIDCR), along with other NIH Institutes and Centers, plans to fund extramural Resource Centers (RCs) to support tissue engineering and regenerative medicine (TE/RM) strategies and products. These RCs will leverage clinical, scientific, industrial, regulatory, and commercialization expertise to guide Interdisciplinary Translational Projects (ITPs) focused on therapeutics, sensors, and diagnostics. The funding will support validation, manufacturing, and preclinical testing of promising products aimed at detecting or treating tissue damage from congenital defects, injury, or chronic disease. The goal is to develop TE/RM products ready for first-in-human studies with regulatory approvals and clinical trial protocols in place. Applications are not currently being solicited; this notice allows potential applicants to prepare for future submissions.

View original listing